BACKGROUND/AIM: Maternal thyroid dysfunction during pregnancy has been associated with adverse obstetric and neonatal outcomes. This prospective study evaluates the prevalence of these disorders in pregnant women. SUBJECTS AND METHODS: Serum levels of TSH, free T4 (fT4), and thyroperoxidase antibodies (TPO-Ab) were measured in 951 women at different gestational ages of pregnancy. Trimester-specific reference ranges for TSH were used to classify pregnant women into five groups: 1) Overt hypothyroidism (OH); 2) Subclinical hypothyroidism (SCH); 3) Isolated hypothyroxinemia (IH); 4) Low TSH (isolated or associated with high fT4); and 5) Normal. A classification was made also according to the lower and upper ranges provided by the manufacturer for thyroid hormones. Pregnant women who were at a high risk of developing thyroid disease were identified. RESULTS: Altogether, 117 women (12.3%) had hypothyroidism and 25 (2.6%) had low TSH. The prevalence of both OH and SCH was higher in the high-risk group than in the low-risk group, but 17.9% of women with hypothyroidism were classified at low-risk. A family history of thyroid disorders and TPO-Ab positivity increased the risk of SCH. Using non-pregnant reference range for TSH, 10.6% of women were misclassificated. CONCLUSIONS: The high prevalence of hypothyroidism observed in this study suggests that accurate thyroid screening with trimester specific reference ranges should be warranted, particularly in areas with mild to moderate iodine deficiencies.
BACKGROUND/AIM: Maternal thyroid dysfunction during pregnancy has been associated with adverse obstetric and neonatal outcomes. This prospective study evaluates the prevalence of these disorders in pregnant women. SUBJECTS AND METHODS: Serum levels of TSH, free T4 (fT4), and thyroperoxidase antibodies (TPO-Ab) were measured in 951 women at different gestational ages of pregnancy. Trimester-specific reference ranges for TSH were used to classify pregnant women into five groups: 1) Overt hypothyroidism (OH); 2) Subclinical hypothyroidism (SCH); 3) Isolated hypothyroxinemia (IH); 4) Low TSH (isolated or associated with high fT4); and 5) Normal. A classification was made also according to the lower and upper ranges provided by the manufacturer for thyroid hormones. Pregnant women who were at a high risk of developing thyroid disease were identified. RESULTS: Altogether, 117 women (12.3%) had hypothyroidism and 25 (2.6%) had low TSH. The prevalence of both OH and SCH was higher in the high-risk group than in the low-risk group, but 17.9% of women with hypothyroidism were classified at low-risk. A family history of thyroid disorders and TPO-Ab positivity increased the risk of SCH. Using non-pregnant reference range for TSH, 10.6% of women were misclassificated. CONCLUSIONS: The high prevalence of hypothyroidism observed in this study suggests that accurate thyroid screening with trimester specific reference ranges should be warranted, particularly in areas with mild to moderate iodine deficiencies.
Authors: Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt Journal: Thyroid Date: 2003-01 Impact factor: 6.568
Authors: R Vissenberg; E van den Boogaard; M van Wely; J A van der Post; E Fliers; P H Bisschop; M Goddijn Journal: Hum Reprod Update Date: 2012-03-19 Impact factor: 15.610
Authors: Jiri Horacek; Sylvie Spitalnikova; Blanka Dlabalova; Eva Malirova; Jaroslav Vizda; Ioannis Svilias; Jitka Cepkova; Catherine Mc Grath; Jaroslav Maly Journal: Eur J Endocrinol Date: 2010-08-03 Impact factor: 6.664
Authors: R Z Klein; J E Haddow; J D Faix; R S Brown; R J Hermos; A Pulkkinen; M L Mitchell Journal: Clin Endocrinol (Oxf) Date: 1991-07 Impact factor: 3.478
Authors: Rt Stricker; M Echenard; R Eberhart; M-C Chevailler; V Perez; F A Quinn; Rn Stricker Journal: Eur J Endocrinol Date: 2007-10 Impact factor: 6.664
Authors: Marcos Abalovich; Nobuyuki Amino; Linda A Barbour; Rhoda H Cobin; Leslie J De Groot; Daniel Glinoer; Susan J Mandel; Alex Stagnaro-Green Journal: J Clin Endocrinol Metab Date: 2007-08 Impact factor: 5.958
Authors: Xia Wang; Ning Tang; Shoji F Nakayama; Pianpian Fan; Zhiwei Liu; Jun Zhang; Fengxiu Ouyang Journal: Environ Sci Pollut Res Int Date: 2020-01-17 Impact factor: 4.223
Authors: R Cannarella; R A Condorelli; F Barbagallo; A Aversa; A E Calogero; S La Vignera Journal: J Endocrinol Invest Date: 2020-10-14 Impact factor: 4.256
Authors: Beverley M Shields; Bridget A Knight; Anita V Hill; Andrew T Hattersley; Bijay Vaidya Journal: J Clin Endocrinol Metab Date: 2013-11-11 Impact factor: 5.958